Richard Newitter
Stock Analyst at Truist Financial
(4.40)
# 1,243
Out of 4,683 analysts
1023
Total ratings
50.4%
Success rate
7.7%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VCEL Vericel | Maintained: Buy | n/a | $43.22 | - | 20 | Aug 20, 2026 | |
| IRTC iRhythm Holdings | Maintained: Buy | n/a | $123.09 | - | 35 | Aug 19, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintained: Hold | $106 | $100.24 | +5.75% | 71 | Aug 11, 2026 | |
| TMCI Treace Medical Concepts | Reiterated: Hold | $4 → $5 | $4.81 | +3.95% | 37 | Aug 10, 2026 | |
| GMED Globus Medical | Reiterated: Buy | $100 | $82.96 | +20.54% | 56 | Aug 7, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Buy | $31 | $21.58 | +43.65% | 9 | Aug 7, 2026 | |
| PODD Insulet | Downgraded: Hold | $210 → $153 | $143.05 | +6.96% | 16 | Aug 6, 2026 | |
| CARL Carlsmed | Reiterated: Buy | $18 → $20 | $16.07 | +24.46% | 8 | Aug 6, 2026 | |
| PRCT PROCEPT BioRobotics | Reiterated: Hold | $21 | $21.60 | -2.78% | 42 | Aug 5, 2026 | |
| ITGR Integer Holdings | Downgraded: Hold | $110 → $127 | $125.39 | +1.28% | 19 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $125 → $103 | $100.87 | +1.62% | 60 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $54 → $62 | $61.07 | +1.52% | 67 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $23 | $19.54 | +17.71% | 17 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $87 → $93 | $89.16 | +4.31% | 11 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $330 → $340 | $330.59 | +2.85% | 49 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $62 → $57 | $49.86 | +14.32% | 52 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $215 | $181.39 | +18.53% | 24 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $19.34 | +13.75% | 14 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $95 | $90.87 | +4.54% | 41 | Jul 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $580 → $510 | $371.84 | +37.16% | 73 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $86 | $91.14 | -5.64% | 48 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $24.48 | -18.30% | 17 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $140.18 | - | 65 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $370 → $374 | $324.37 | +15.30% | 27 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $68.62 | - | 1 | Jan 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 | $16.79 | -22.57% | 33 | Dec 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $126.64 | n/a | 1 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $21.59 | n/a | 1 | Jun 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $260.23 | n/a | 1 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $11.68 | n/a | 1 | Jun 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.82 | n/a | 1 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $148 | $179.37 | n/a | 1 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.74 | n/a | 10 | Oct 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $6.40 | n/a | 3 | Sep 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 57.03 → CHF 65.87 | CHF 58.72 | n/a | 11 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $154.77 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $260 → $250 | $189.78 | n/a | 16 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $49.93 | n/a | 13 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $8.94 | n/a | 3 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $770 | $159.61 | n/a | 26 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $141 | $51.13 | n/a | 14 | Jul 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $45 | $116.13 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $48.68 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $47 | $26.29 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $140 | $273.14 | n/a | 1 | Jul 15, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $4.5 | $9.52 | n/a | 1 | Jul 15, 2016 |
Vericel
Aug 20, 2026
Maintained: Buy
Price Target: n/a
Current: $43.22
Upside: -
iRhythm Holdings
Aug 19, 2026
Maintained: Buy
Price Target: n/a
Current: $123.09
Upside: -
Zimmer Biomet Holdings
Aug 11, 2026
Maintained: Hold
Price Target: $106
Current: $100.24
Upside: +5.75%
Treace Medical Concepts
Aug 10, 2026
Reiterated: Hold
Price Target: $4 → $5
Current: $4.81
Upside: +3.95%
Globus Medical
Aug 7, 2026
Reiterated: Buy
Price Target: $100
Current: $82.96
Upside: +20.54%
Tandem Diabetes Care
Aug 7, 2026
Reiterated: Buy
Price Target: $31
Current: $21.58
Upside: +43.65%
Insulet
Aug 6, 2026
Downgraded: Hold
Price Target: $210 → $153
Current: $143.05
Upside: +6.96%
Carlsmed
Aug 6, 2026
Reiterated: Buy
Price Target: $18 → $20
Current: $16.07
Upside: +24.46%
PROCEPT BioRobotics
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $21.60
Upside: -2.78%
Integer Holdings
Aug 4, 2026
Downgraded: Hold
Price Target: $110 → $127
Current: $125.39
Upside: +1.28%
Aug 4, 2026
Downgraded: Hold
Price Target: $125 → $103
Current: $100.87
Upside: +1.62%
Aug 4, 2026
Reiterated: Hold
Price Target: $54 → $62
Current: $61.07
Upside: +1.52%
Aug 4, 2026
Reiterated: Buy
Price Target: $21 → $23
Current: $19.54
Upside: +17.71%
Jul 31, 2026
Reiterated: Buy
Price Target: $87 → $93
Current: $89.16
Upside: +4.31%
Jul 31, 2026
Reiterated: Hold
Price Target: $330 → $340
Current: $330.59
Upside: +2.85%
Jul 30, 2026
Rated: Buy
Price Target: $62 → $57
Current: $49.86
Upside: +14.32%
Jul 30, 2026
Reiterated: Buy
Price Target: $180 → $215
Current: $181.39
Upside: +18.53%
Jul 30, 2026
Reiterated: Buy
Price Target: $22
Current: $19.34
Upside: +13.75%
Jul 24, 2026
Reiterated: Hold
Price Target: $95
Current: $90.87
Upside: +4.54%
Jul 17, 2026
Reiterated: Buy
Price Target: $580 → $510
Current: $371.84
Upside: +37.16%
Jun 4, 2026
Rated: Hold
Price Target: $86
Current: $91.14
Upside: -5.64%
Mar 2, 2026
Reiterated: Hold
Price Target: $20
Current: $24.48
Upside: -18.30%
Feb 27, 2026
Maintained: Hold
Price Target: n/a
Current: $140.18
Upside: -
Jan 16, 2026
Downgraded: Hold
Price Target: $370 → $374
Current: $324.37
Upside: +15.30%
Jan 16, 2026
Maintained: Buy
Price Target: n/a
Current: $68.62
Upside: -
Dec 23, 2025
Reiterated: Hold
Price Target: $13
Current: $16.79
Upside: -22.57%
Jun 26, 2025
Maintained: Buy
Price Target: n/a
Current: $126.64
Upside: n/a
Jun 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $21.59
Upside: n/a
Oct 16, 2024
Rated: Buy
Price Target: n/a
Current: $260.23
Upside: n/a
Jun 20, 2024
Rated: Buy
Price Target: n/a
Current: $11.68
Upside: n/a
Apr 17, 2024
Reiterated: Buy
Price Target: n/a
Current: $25.82
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $148
Current: $179.37
Upside: n/a
Oct 7, 2021
Maintained: Buy
Price Target: n/a
Current: $1.74
Upside: n/a
Sep 10, 2021
Initiated Coverage: Buy
Price Target: $20
Current: $6.40
Upside: n/a
Aug 17, 2021
Maintained: Hold
Price Target: CHF 57.03 → CHF 65.87
Current: CHF 58.72
Upside: n/a
Aug 6, 2021
Rated: Buy
Price Target: n/a
Current: $154.77
Upside: n/a
Aug 5, 2021
Rated: Hold
Price Target: $260 → $250
Current: $189.78
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $27
Current: $49.93
Upside: n/a
Aug 5, 2021
Reiterated: Buy
Price Target: $20
Current: $8.94
Upside: n/a
Jul 28, 2021
Rated: Buy
Price Target: $770
Current: $159.61
Upside: n/a
Jul 28, 2021
Rated: Hold
Price Target: $141
Current: $51.13
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $45
Current: $116.13
Upside: n/a
Jul 15, 2016
Reiterated: Buy
Price Target: $20
Current: $48.68
Upside: n/a
Jul 15, 2016
Rated: Hold
Price Target: $47
Current: $26.29
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $140
Current: $273.14
Upside: n/a
Jul 15, 2016
Rated: Buy
Price Target: $4.5
Current: $9.52
Upside: n/a